Investor AB (publ)
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IVSXF research report →
Price Chart
About the company
Investor AB (publ) functions as an investment firm primarily focused on venture capital activities. Its expertise lies in growth capital, buyouts, and investments within mature, mid-market companies. The company’s operations are structured into four main segments: Core Investments, Private Equity, Operating Investments, and Financial Investments.
- CEO
- Ulf Christian Cederholm
- IPO
- 2010
- Employees
- 19,351
- HQ
- Stockholm, AB, SE
Get TickerSpark's AI analysis on IVSXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $123.96B
- P/E
- 5.82
- Fwd P/E
- 1.81
- PEG
- 0.03
- P/S
- 4.95
- P/B
- 1.14
- EV/EBITDA
- 6.21
- Div Yield
- 1.37%
- Gross Margin
- 91.85%
- Op Margin
- 86.97%
- Net Margin
- 84.96%
- ROE
- 20.83%
- ROIC
- 17.25%
Latest fiscal year · YoY change
- Revenue
- $221.86B+28.4%
- Gross Profit
- $217.18B+28.6%
- Op Income
- $158.45B
- Net Income
- $157.49B+39.0%
- EPS
- $51.42+39.0%
- OCF Growth
- -6.0%
- FCF Growth
- -0.9%
- 52W High
- $43.50
- 52W Low
- $32.50
- 50D MA
- $40.75
- 200D MA
- $40.06
- Beta
- 0.78
- RSI (14)
- 37
- Avg Volume
- 176
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Investor posted a solid Q3, with adjusted NAV up 4% as Patricia Industries and EQT drove the quarter and management reiterated confidence in the portfolio and capital allocation framework.· October 16, 2026
- Adjusted NAV rose 4% quarter over quarter to SEK 1,258 billion; total shareholder return on the B share was 1%.
- Patricia Industries was the standout, with a 15% total return, 7% organic sales growth and 26% adjusted EBITA growth at the major subsidiaries.
- Listed Companies had a 1% total return, with Saab, SEB and Nasdaq stronger while industrials and consumer holdings were weaker.
- Investments in EQT returned 7%, supported by EQT AB and fund investments; Investor invested SEK 0.7 billion net of exit proceeds in the funds.
- Management highlighted Mölnlycke’s planned split, continued strong execution at Nova Biomedical and Laborie, and a balance sheet with SEK 29 billion in cash and 1.8% leverage.
In Q3 2026, adjusted net asset value was SEK 1,258 billion, up 4% versus Q2. Total shareholder return for the Investor B share was 1%. Listed Companies generated a 1% total return, or 1 percentage point behind SIXRX. Patricia Industries generated a 15% total return, driven by strong operating performance, multiple expansion and positive currency impact. The major subsidiaries delivered 7% organic sales growth and 26% adjusted EBITA growth, helped by M&A, FX and tariff refunds. Investments in EQT returned 7%, driven by EQT AB and fund investments. Estimated market values for Patricia Industries increased 15% sequentially, from SEK 222 billion to SEK 256 billion. The balance sheet leverage was 1.8%, cash at hand was SEK 29 billion, and Moody’s upgraded Investor from Aa3 to Aa2. No explicit quarterly or full-year financial guidance was provided beyond commentary that most tariff refunds have likely been seen and that capital allocation will continue to prioritize existing companies, a steadily rising dividend, and new platform investments over time.
Christian Cederholm framed the quarter as evidence of the resilience and quality of Investor’s platform, saying all business areas contributed and that the company remains confident in its portfolio. He emphasized strong execution in Patricia Industries, particularly at Mölnlycke, Nova Biomedical and Laborie, and pointed to strategic actions like Mölnlycke’s planned separation and EQT’s acquisitions as value-creating steps. His tone was constructive and steady, with repeated emphasis on long-term ownership, focus and supporting the existing portfolio.
Jenny Ashman Haquinius walked through the quarter’s mechanics: adjusted NAV of SEK 1,258 billion, up 4%, with Patricia Industries up 15% and Investments in EQT up 7%. She highlighted that the major subsidiaries grew 7% organically and 26% in adjusted EBITA, with profitability aided by M&A, positive FX and tariff refunds; she also said tariff refunds were roughly a percentage point on margins for the businesses where they were highlighted. On the balance sheet, she pointed to 1.8% leverage, SEK 29 billion of cash, and the Moody’s upgrade to Aa2, underscoring financial strength and flexibility.
Analysts focused heavily on Mölnlycke’s Wound Care growth, the planned split of Mölnlycke, and the durability of margins at Nova and Laborie. Management said Mölnlycke’s 6% Wound Care growth looked solid but cautioned against extrapolating from one quarter, noting mature-market growth is typically low to mid-single digits and competition remains tough in the U.S. and France. On the split, Christian said the goal is more focus, accountability and innovation, not a sale or a multiple re-rating, while Jenny said Nova is still early in integration and Laborie’s growth is being driven by Optilume urethral strictures, with BPH still in an early launch stage. They also said the bulk of tariff refunds has likely been seen, and that SEB share sales are not a standing policy but are driven by regulatory considerations.
The strongest positive signal from the call is that the portfolio is broadening beyond one or two names: Patricia Industries delivered strong organic growth and profit expansion across several businesses, while EQT and the listed portfolio also contributed. Management also sees multiple ways to create value going forward, including Mölnlycke’s split, continued innovation, and ongoing capital deployment into attractive opportunities. The balance sheet remains conservative, giving Investor flexibility in a volatile environment.
The call also pointed to a few clear headwinds: Listed Companies lagged the benchmark, ABB was a drag, and management acknowledged tougher conditions in industrials, consumer holdings, and in parts of Mölnlycke’s markets. Mölnlycke’s U.S. prevention business faces tough competition, ORS still has room to grow, and management said the split will add costs and take time before any “sum of the parts” benefit shows through. In addition, tariff refunds appear mostly behind the company, reducing one temporary margin tailwind.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 79.7%
- Shares Outstanding
- 3.06B
- Float Shares
- 2.44B
Our IVSXF coverage
Recent articles, reports, and earnings notes.
No research on IVSXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IVSXF report →Marvell: Investor Day Resets The AI Growth Story
seekingalpha.com · Oct 8
Stellantis Presents FaSTLAne 2030 Financial Framework & Targets at Investor Day 2026
globenewswire.com · May 21
Stellantis to Present New Strategic Plan Today at Investor Day 2026
globenewswire.com · May 21
Stellantis to Present Strategic Plan at May 21 Investor Day
globenewswire.com · Jan 29
Investor AB (publ) (IVSBF) Q4 2025 Earnings Call Transcript
seekingalpha.com · Jan 22
RioCan Real Estate Investment Trust Announces Investor Day and Third Quarter 2025 Earnings Release, Conference Call and Webcast
businesswire.com · Oct 2
Investor AB: Better NAV Discounts Are Out There
seekingalpha.com · Aug 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.